Industrial Gases & Fuels · Founded 1973 · www.ellenbarrie.com · BSE 544421 · NSE ELLEN · ISIN INE236E01022
No Notes Added Yet
Business
Ellenbarrie Industrial Gases Ltd. is an Indian company engaged in the manufacturing and distribution of a wide range of industrial, medical, and specialty gases. Its core business involves producing atmospheric gases (Oxygen, Nitrogen, Argon) using air separation units, as well as process gases (Dissolved Acetylene, Carbon Dioxide, Hydrogen, Nitrous Oxide). The company supplies these gases in various modes, including high-pressure cylinders, cryogenic liquid tanks (bulk supply), and through on-site pipeline installations. It serves diverse sectors such as metal fabrication, healthcare, chemicals, pharmaceuticals, food & beverage, automotive, and general manufacturing, making money through the sale and distribution of these essential gases.
Revenue Mix
Ellenbarrie's primary revenue streams come from the sale of:
Industrial Gases: Oxygen, Nitrogen, Argon, Acetylene, Carbon Dioxide, Hydrogen for manufacturing and industrial processes.
Medical Gases: Medical Oxygen, Nitrous Oxide for healthcare facilities.
Specialty Gases & Mixtures: High-purity gases and custom gas mixtures for precise industrial applications, R&D, and calibration.
While specific percentage breakdowns are not always publicly detailed for such companies, the revenue mix is diversified across these categories and their respective end-use industries.
Industry
The industrial gases industry in India is capital-intensive, energy-intensive, and highly technical. It is largely dominated by a few global majors (e.g., Linde India, Air Liquide, Inox Air Products) which have extensive infrastructure and global R&D capabilities. Ellenbarrie Industrial Gases operates as a significant regional player, particularly strong in Eastern India and with presence in other parts of the country. It competes with both the large multinational players and numerous smaller regional manufacturers. Its positioning relies on its established distribution network, customer relationships, and ability to cater to local industrial demand efficiently.
MOAT
Ellenbarrie's competitive advantages are primarily derived from:
Regional Density & Distribution Network: A well-established and efficient distribution network in its core operating regions allows for timely and cost-effective delivery to local customers, which is crucial for heavy and bulky products like industrial gases.
Customer Relationships: Long-standing relationships and consistent service quality with regional industrial clients create a degree of stickiness.
Diversified Product Portfolio: Offering a broad range of gases, from common industrial gases to specialty mixtures, caters to varied customer needs and reduces reliance on a single product.
Strategic Plant Locations: Proximity of manufacturing units to key industrial clusters minimizes logistics costs and enhances supply reliability.
Growth Drivers
Indian Industrial Growth: The "Make in India" initiative and ongoing infrastructure development (steel, cement, automotive, chemicals) are expected to drive robust demand for industrial gases.
Healthcare Sector Expansion: Increasing healthcare spending and the expansion of medical facilities, especially post-pandemic awareness regarding medical oxygen, will boost demand for medical gases.
Rise of Specialty Gases: Growing adoption of high-purity and specialty gases in advanced manufacturing, electronics, and R&D will open new market opportunities.
Geographic Expansion: Potential to expand operations into new industrial belts or deepen penetration in existing underserved regions within India.
Increased Manufacturing Output: General growth in manufacturing output across various sectors directly translates to higher consumption of industrial gases.
Risks
Intense Competition & Pricing Pressure: The industry faces strong competition from large global players with greater economies of scale and pricing power, which can impact Ellenbarrie's margins.
High Capital Expenditure (CAPEX): Setting up and expanding gas production facilities (air separation units) and maintaining cylinder fleets requires significant and ongoing capital investments.
Energy Costs: Production of industrial gases, particularly atmospheric gases, is highly energy-intensive. Fluctuations in power tariffs can significantly impact operational costs and profitability.
Economic Downturns: Demand for industrial gases is cyclical and closely tied to the overall health of the manufacturing sector. An economic slowdown can lead to reduced industrial output and gas consumption.
Regulatory & Environmental Compliance: Strict safety, environmental, and transportation regulations for hazardous goods can impose compliance costs and operational constraints.
Logistics & Transportation Costs: The bulkiness and specialized handling requirements of gases mean that transportation costs can be substantial and susceptible to fuel price volatility.
Management & Ownership
Ellenbarrie Industrial Gases Ltd. is promoted and managed by the Modi family, who have a long history and experience in the industrial gases sector in India. The promoter group typically holds a significant majority stake in the company (often in the range of 70-75%), indicating a strong alignment of interests between management and shareholders. The management team is generally characterized by its operational expertise and focus on regional market development.
Outlook
Ellenbarrie Industrial Gases is well-positioned to benefit from India's long-term industrialization and growth in manufacturing and healthcare sectors. The increasing demand for both bulk industrial gases and specialized applications provides a secular tailwind. However, the company operates in a highly competitive, capital-intensive, and energy-sensitive industry. Its ability to navigate intense competition from larger players, manage input costs effectively, and judiciously expand its regional presence and product offerings will be key to its sustained performance. The significant promoter holding provides stability and long-term vision, but success will hinge on strategic investments and maintaining operational efficiencies in a dynamic market.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2016 | Dec 2016 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 29 | 24 | 67 | 95 | 68 | 82 | 84 | 89 | 81 | 87 |
| Other Income | -0 | 0 | 8 | 7 | 9 | 11 | 7 | 13 | 16 | 15 |
| Total Income | 29 | 25 | 75 | 102 | 77 | 94 | 90 | 102 | 97 | 102 |
| Total Expenditure | 23 | 20 | 45 | 58 | 41 | 58 | 53 | 56 | 56 | 60 |
| Operating Profit | 6 | 5 | 30 | 43 | 36 | 36 | 38 | 46 | 41 | 42 |
| Interest | 3 | 2 | 4 | 4 | 4 | 5 | 5 | 1 | 1 | 2 |
| Depreciation | 2 | 2 | 5 | 5 | 5 | 7 | 5 | 5 | 5 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 1 | 21 | 34 | 28 | 24 | 28 | 40 | 34 | 33 |
| Provision for Tax | 0 | 0 | 5 | 5 | 9 | 6 | 9 | 3 | 8 | 10 |
| Profit After Tax | 2 | 1 | 16 | 30 | 19 | 18 | 19 | 37 | 26 | 23 |
| Adjustments | -2 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 16 | 30 | 19 | 18 | 19 | 37 | 26 | 23 |
| Adjusted Earnings Per Share | 0.1 | 0.1 | 1.2 | 2.3 | 1.5 | 1.4 | 1.3 | 2.6 | 1.9 | 1.6 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 87 | 96 | 116 | 123 | 154 | 174 | 175 | 245 | 205 | 269 | 312 | 341 |
| Other Income | 6 | 4 | 2 | 3 | 2 | 123 | 5 | 11 | 19 | 21 | 36 | 51 |
| Total Income | 93 | 100 | 119 | 126 | 156 | 297 | 180 | 256 | 224 | 290 | 348 | 391 |
| Total Expenditure | 83 | 90 | 100 | 105 | 125 | 149 | 129 | 164 | 171 | 208 | 203 | 225 |
| Operating Profit | 10 | 9 | 19 | 21 | 31 | 148 | 51 | 92 | 52 | 82 | 146 | 167 |
| Interest | 13 | 16 | 11 | 11 | 14 | 17 | 11 | 5 | 4 | 8 | 17 | 9 |
| Depreciation | 5 | 7 | 7 | 7 | 10 | 11 | 13 | 12 | 11 | 10 | 21 | 21 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -9 | -13 | 0 | 2 | 7 | 120 | 27 | 85 | 37 | 64 | 108 | 135 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 30 | 3 | 18 | 9 | 19 | 25 | 30 |
| Profit After Tax | -9 | -13 | 0 | 2 | 7 | 89 | 24 | 67 | 28 | 45 | 83 | 105 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -9 | -13 | 0 | 2 | 7 | 89 | 24 | 67 | 28 | 45 | 83 | 105 |
| Adjusted Earnings Per Share | -0.7 | -1 | 0 | 0.2 | 0.6 | 6.8 | 1.8 | 5.1 | 2.1 | 3.5 | 6.4 | 7.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 16% | 8% | 12% | 14% |
| Operating Profit CAGR | 78% | 17% | -0% | 31% |
| PAT CAGR | 84% | 7% | -1% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | -1% |
| ROE Average | 19% | 14% | 18% | 37% |
| ROCE Average | 20% | 15% | 18% | 16% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 13 | 31 | 22 | 24 | 31 | 124 | 148 | 338 | 363 | 410 | 493 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 125 | 131 | 114 | 145 | 142 | 112 | 86 | 0 | 56 | 95 | 147 |
| Other Non-Current Liabilities | 0 | 0 | 5 | 5 | 7 | 40 | 41 | 56 | 67 | 56 | 91 |
| Total Current Liabilities | 100 | 67 | 90 | 87 | 102 | 71 | 96 | 50 | 107 | 135 | 161 |
| Total Liabilities | 238 | 229 | 231 | 262 | 282 | 346 | 371 | 444 | 592 | 697 | 891 |
| Fixed Assets | 164 | 165 | 163 | 163 | 196 | 229 | 238 | 187 | 184 | 331 | 339 |
| Other Non-Current Assets | 2 | 3 | 17 | 38 | 17 | 25 | 24 | 92 | 196 | 112 | 331 |
| Total Current Assets | 73 | 62 | 51 | 60 | 68 | 93 | 109 | 164 | 212 | 254 | 222 |
| Total Assets | 238 | 229 | 231 | 262 | 282 | 346 | 371 | 444 | 592 | 697 | 891 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 2 | 0 | 1 | 1 | 2 | 39 | 1 | 0 | 11 | 1 |
| Cash Flow from Operating Activities | 12 | -13 | 34 | -1 | 33 | 125 | 71 | 31 | 39 | 44 | 4 |
| Cash Flow from Investing Activities | -43 | -8 | -8 | -27 | -20 | -37 | -14 | -41 | -114 | -122 | -57 |
| Cash Flow from Financing Activities | 32 | 22 | -26 | 28 | -12 | -51 | -34 | 10 | 87 | 67 | 52 |
| Net Cash Inflow / Outflow | 1 | -0 | 0 | -0 | 1 | 37 | 22 | -0 | 11 | -10 | -1 |
| Closing Cash & Cash Equivalent | 2 | 2 | 1 | 1 | 2 | 39 | 62 | 0 | 11 | 1 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.66 | -1.02 | 0.03 | 0.19 | 0.56 | 6.83 | 1.84 | 5.13 | 2.15 | 3.46 | 6.36 |
| CEPS(Rs) | -0.26 | -0.47 | 0.56 | 0.75 | 1.33 | 7.63 | 2.82 | 6.01 | 3.02 | 4.22 | 7.94 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -0.78 | -0.23 | -0.1 | 0.1 | 0.63 | 7.69 | 9.5 | 24.07 | 25.96 | 29.53 | 35.91 |
| Core EBITDA Margin(%) | 4.51 | 5.66 | 14.01 | 14.63 | 19.28 | 14.4 | 26.36 | 32.94 | 16.41 | 22.86 | 35.15 |
| EBIT Margin(%) | 4.78 | 2.27 | 10.08 | 11.02 | 13.78 | 78.65 | 21.77 | 36.61 | 19.93 | 26.84 | 40.02 |
| Pre Tax Margin(%) | -9.18 | -12.87 | 0.33 | 2.03 | 4.79 | 68.61 | 15.68 | 34.72 | 18.17 | 23.83 | 34.51 |
| PAT Margin (%) | -9.18 | -12.87 | 0.33 | 2.03 | 4.79 | 51.31 | 13.73 | 27.46 | 13.72 | 16.81 | 26.65 |
| Cash Profit Margin (%) | -3.6 | -6 | 6.37 | 7.94 | 11.27 | 57.36 | 21.09 | 32.17 | 19.27 | 20.52 | 33.28 |
| ROA(%) | -4.1 | -5.7 | 0.17 | 1.01 | 2.72 | 28.48 | 6.71 | 16.49 | 5.43 | 7.03 | 10.49 |
| ROE(%) | 0 | 0 | 0 | 0 | 155.5 | 164.16 | 21.37 | 30.56 | 8.59 | 12.47 | 19.44 |
| ROCE(%) | 2.72 | 1.24 | 6.27 | 6.82 | 9.82 | 59.76 | 15.44 | 30.72 | 10.66 | 14.4 | 19.55 |
| Receivable days | 74.08 | 88.75 | 84.03 | 90.22 | 73.7 | 69.64 | 67.77 | 48.24 | 67.38 | 57.37 | 74.72 |
| Inventory Days | 35.68 | 35.93 | 18.88 | 10.83 | 8.07 | 7.95 | 9.59 | 10.25 | 15.23 | 13.16 | 14.72 |
| Payable days | 128.85 | 112.74 | 71.84 | 89.02 | 175.53 | 350.62 | 502.39 | 223.42 | 238 | 117.6 | 162.43 |
| PER(x) | 0 | 0 | 523.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | -36.33 | -67.71 | -150.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 6.55 | 4.08 | 3.35 | 1.73 | 1.33 | 0.57 | 0.42 | 0.06 | 0.45 | 0.67 | 0.86 |
| EV/Core EBITDA(x) | 58.45 | 41.37 | 20.76 | 10.24 | 6.54 | 0.67 | 1.46 | 0.15 | 1.78 | 2.18 | 1.84 |
| Net Sales Growth(%) | 28.66 | 9.95 | 20.93 | 6.09 | 25.32 | 12.92 | 0.5 | 39.65 | -16.14 | 31.38 | 15.96 |
| EBIT Growth(%) | 121.18 | -47.88 | 397.28 | 16.02 | 56.64 | 544.68 | -72.19 | 134.89 | -54.35 | 76.92 | 72.92 |
| PAT Growth(%) | 68.07 | -53.48 | 102.91 | 543 | 196.13 | 1110.01 | -73.1 | 179.23 | -58.09 | 60.93 | 83.91 |
| EPS Growth(%) | 68.07 | -53.49 | 102.91 | 543.92 | 195.96 | 1110.07 | -73.1 | 179.36 | -58.09 | 60.93 | 83.91 |
| Debt/Equity(x) | -19.85 | 23.83 | -139.52 | 165.83 | 25.94 | 1.35 | 1.07 | 0.03 | 0.3 | 0.46 | 0.52 |
| Current Ratio(x) | 0.73 | 0.92 | 0.57 | 0.69 | 0.67 | 1.31 | 1.14 | 3.28 | 1.99 | 1.87 | 1.38 |
| Quick Ratio(x) | 0.61 | 0.8 | 0.52 | 0.65 | 0.64 | 1.25 | 1.09 | 3.11 | 1.91 | 1.79 | 1.29 |
| Interest Cover(x) | 0.34 | 0.15 | 1.03 | 1.23 | 1.53 | 7.84 | 3.58 | 19.33 | 11.31 | 8.93 | 7.26 |
| Total Debt/Mcap(x) | 0.55 | 0.87 | 0.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.94 | 74.94 | 0 | 74.94 | 74.94 | 29.65 | 77.16 | 77.16 | 77.16 | 77.15 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 1.97 | 1.2 | 0.83 | 1.31 |
| DII | 0.62 | 0.62 | 2.47 | 0.62 | 0.62 | 0.24 | 10.57 | 14.37 | 14.34 | 13.02 |
| Public | 24.44 | 24.44 | 97.53 | 24.44 | 24.44 | 70.1 | 10.3 | 7.27 | 7.67 | 8.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.49 | 0.49 | 0 | 0.49 | 0.49 | 0.49 | 10.87 | 10.87 | 10.87 | 10.87 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.28 | 0.17 | 0.12 | 0.18 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 1.49 | 2.03 | 2.02 | 1.83 |
| Public | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 1.16 | 1.45 | 1.02 | 1.08 | 1.2 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.65 | 0.65 | 0.16 | 0.65 | 0.65 | 1.65 | 14.09 | 14.09 | 14.09 | 14.09 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +16% | +8% | +12% | +14% |
| Operating Profit CAGR | +78% | +17% | 0% | +31% |
| PAT CAGR | +84% | +7% | -1% | — |
| Share Price CAGR | — | — | — | -1% |
| ROE Average | +19% | +14% | +18% | +37% |
| ROCE Average | +20% | +15% | +18% | +16% |
| # | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.94 | 74.94 | 0 | 74.94 | 74.94 | 29.65 | 77.16 | 77.16 | 77.16 | 77.15 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 1.97 | 1.2 | 0.83 | 1.31 |
| DII | 0.62 | 0.62 | 2.47 | 0.62 | 0.62 | 0.24 | 10.57 | 14.37 | 14.34 | 13.02 |
| Public | 25.06 | 25.06 | 100 | 25.06 | 25.06 | 70.35 | 22.84 | 22.84 | 22.84 | 22.85 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.49 | 0.49 | 0 | 0.49 | 0.49 | 0.49 | 10.87 | 10.87 | 10.87 | 10.87 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.28 | 0.17 | 0.12 | 0.18 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 1.49 | 2.03 | 2.02 | 1.83 |
| Public | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 1.16 | 3.22 | 3.22 | 3.22 | 3.22 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.65 | 0.65 | 0.16 | 0.65 | 0.65 | 1.65 | 14.09 | 14.09 | 14.09 | 14.09 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.